Abstract
AimThe purpose of this study is to investigate the clinical use of sleep aids, specifically melatonin for sleep disorders in children and adolescents in treated at various facilities in Uppsala County, SwedenMethodA cross sectional study was conducted using a short 9 question web‐based survey. The survey contained questions about sleep medications in general and some specific questions about melatonin/Circadin®. The questionnaire was then sent to doctors in various clinics in Uppsala County, Sweden.ResultsPreliminary results shows that the majority of the doctors prescribe some sort of sleep aid, where Circadin® was the most commonly prescribed sleep aid; with melatonin as a close second (Melatonin not an OTC‐drug in Sweden). Sleep aid was prescribed to children of all ages; and most often in conjunction to various neuropsychiatric disorders. The average dose was 2‐3 mg melatonin /Circadin® per day, with some prescribing up to 6 or 9 mg per day.ConclusionThese preliminary results indicate that the doctors prescribe Circadin® to a larger degree. This despite that Circadin®'s current indication is for people >55 years old. Moreover, high doses of melatonin are prescribed, most probably leading to next‐day drowsiness and sub‐optimal functioning of the children. Doctors need to be informed about proper choice of drug and dose for the pediatric patient
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
